Holy Cross Health’s Wound Healing Program Honored for Excellence
Holy Cross Health’s Wound Healing and Hyperbaric Program has been awarded the Center of Distinction honor by Healogics, the largest provider of advanced wound care services in the United States. This recognition is a result of the program’s exceptional clinical outcomes over twelve consecutive months, including a patient satisfaction rate exceeding 92 percent. Margie Garland, Program Director, highlighted the achievement as a reflection of the quality care provided to patients, acknowledging the contributions of Dr. William Ward and Joly, the medical director and clinical coordinator, respectively.
The program, part of the Healogics network, specializes in treating chronic wounds such as diabetic foot ulcers and pressure ulcers, employing advanced therapies like negative pressure wound therapy and hyperbaric oxygen therapy. These treatments are designed to accelerate healing and improve patient outcomes. The Center of Distinction award underscores the program’s commitment to excellence in wound care and its role in enhancing the quality of life for patients with chronic wounds.
Holy Cross Health’s recognition by Healogics not only highlights the program’s success but also sets a benchmark for wound care services nationwide. The award is a testament to the dedication of the healthcare professionals at Holy Cross Health and their unwavering focus on patient-centered care. For more information on the advanced wound care services offered by Holy Cross Health, visit https://holy-cross.com.
This news story relied on content distributed by None. Blockchain Registration, Verification & Enhancement provided by NewsRamp
. The source URL for this press release is Holy Cross Health’s Wound Healing Program Honored for Excellence.
More From Montreal Breaking
New Book Sheds Light on the Realities of...
With an increasing number of Americans contemplating a move abroad, Portugal has become the premier...
Japanese FSA Proposes Lower Taxes and Reclassification for...
The Japanese Financial Services Agency (FSA) has put forward a proposal that could dramatically alter...
ESGold Corp. Featured in NetworkNewsWire Editorial for Innovative...
ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) has been featured in a NetworkNewsWire editorial, shedding light...
NanoViricides Announces Promising Results for Measles Treatment in...
NanoViricides, Inc. (NYSE American: NNVC), a clinical-stage developer of broad-spectrum antivirals, has announced promising results...